LCZ696A

sacubitril/valsartan · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LCZ696A, covering 2015-08-10 to 2015-08-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of LCZ696A in Patients With Essential Hypertension [Phase 2]